Pfizer Secretly Added Language Warning About ‘Unfavorable Pre-Clinical, Clinical Or Safety Data’ May Affect Business!

Fourteen days ago, the FDA begged Texas judge to delay production on the first month batch of 55,000 pages of C-19 vaccine data submitted to the agency by Pfizer. The agency was set to produce 500 pages a month.

Pfizer, forecast $54 billion in C-19 linked sales in 2022, seems to have bad news, as evidenced by many redline changes in the Q4 earnings releases.

Join The True Defender Telegram Chanel Here:

Rubicon Capital’s Kelly Brown emphasized that the changes center around disclosures of unfavorable safety data.
In Q4, they added: “or further information regarding the quality of pre-clinical, clinical or safety data, including by audit or inspection.”


Brown noted that Pfizer highlights concerns about clinical data integrity.

The company noted that C-19 may “diminish in severity or prevalence, or disappear entirely.”

Watch the video below:


Banned Video Info Wars Twitter Banned Video

Leave a Reply

Your email address will not be published. Required fields are marked *